Gate Bioscience
Gate Bioscience is a biotechnology company developing molecular gates, a new class of small molecule medicines that eliminate disease-causing proteins at their source. Gate’s proprietary Molecular Gate Discovery Platform enables the rapid and repeatable discovery of selective molecular gates against high-value targets across inflammatory and neurological diseases.
Leadership & Board
- Current Number of Employees
- 41
- Current LinkedIn Followers
- 4,259
Latest Estimated Valuation
- Estimated Valuation
- ―
- Total Amount Raised
- $65M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $65M
- Latest Funding Round
- Series B
- Post-Money Valuation
- ―
Company Momentum Positive
Gate Bioscience LinkedIn following is increasing, signaling rising market interest, while its workforce is growing, indicating business expansion.
Employee Trend
Gate Bioscience had 41 employees as of October 12, 2026. The number of employees increased by 0 (0.00%) week-over-week.
Social Trend
Gate Bioscience had 4,259 followers as of October 12, 2026. The number of followers increased by 116 (2.80%) week-over-week.
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Nov 13, 2025 | Series B | $65.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Eli Lilly and Company | Series B |
| Forbion | Series B |
| GV | Series B |
| Versant Ventures | Series B |
| ARCH Venture Partners | Series B |
| Andreessen Horowitz | Series B |
Similar Companies
A snapshot of private companies similar to Gate Bioscience, helping you discover and navigate related company profiles.
Related News and Analysis
